content_image/292200.jpg content_image/292201.jpg
The table below reconciles our Adjusted EBITDA with measures that are found in our financial statements. 

<img src='content_image/292200.jpg'>

The results for the fourth quarter were affected by most of the same items discussed in Sections 5.3 and 5.4, which discussed performance in fiscal 2013 compared to fiscal 2012. These items include soft U.S. restaurant sales, lower retail private label value-added product sales, and higher production and distribution costs in the U.S. In addition, in the fourth quarter of 2013, sales from our Canadian retail business were lower compared to the same period last year, due to changes in the timing of customer promotions and increased competition from other proteins. 

The effective income tax rate for the fourth quarter of 2013 was 20.1% compared to the applicable statutory rate in Canada of approximately 27.9% and the statutory rate in the U.S. of 38.9%. The effective income tax rate in the fourth quarter of 2013 is lower than the statutory rate due primarily to the benefit of acquisition financing deductions. 

The effective income tax rate for the fourth quarter of 2012 was a recovery of 38.5% compared to the applicable statutory rate in Canada of approximately 27.3% and the statutory rate in the U.S. of 38.9%. The income tax recovery in the fourth quarter of 2012 is higher than the statutory rate due to the benefit of acquisition financing deductions in connection with the Viking and Icelandic USA acquisitions, partially offset by non-deductible stock-based compensation expense and the income of the U.S. subsidiary where the statutory tax rate is higher. 

The table below shows the impact of non-operating, one-time acquisition costs, stock compensation expense and adjusting income taxes for withholding tax paid on an intercompany dividend excluded from Adjusted Net Income on our Adjusted Diluted EPS for the fourth quarters of 2013 and 2012. 

<img src='content_image/292201.jpg'>

Adjusted Net Income increased in 2013 by $1.3 million, or 12.2%, and Adjusted Diluted EPS increased by $0.08 per share. 

